down arrow

Aarti Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0LRU01027
  • NSEID: AARTIPHARM
  • BSEID: 543748
INR
675.60
49 (7.82%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.83 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

646.50679.90

52 Week

429.50837.00
Valuation
Technical
Day's Volume

CASH

6.83 lacs (-21.69%) Volume

Shareholding (Dec 2024)

FII

8.64%

Held by 100 FIIs

DII

10.37%

Held by 8 DIIs

Promoter

44.66%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.71 times

 
2

Healthy long term growth as Operating profit has grown by an annual rate 37.76%

 
3

Flat results in Dec 24

4

Stock is technically in a Mildly Bullish range

5

With ROCE of 15.1, it has a Fair valuation with a 2.8 Enterprise value to Capital Employed

6

Reducing Promoter Confidence

7

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 6,123 Cr (Mid Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.56%

stock-summary
Debt Equity

0.15

stock-summary
Return on Equity

12.28%

stock-summary
Price to Book

3.06

Revenue and Profits (1 Year):
Net Sales:
538 Cr
(Quarterly Results - Dec 2024)
Net Profit:
74 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.56%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
11.29%
0.40%
11.69%
1 Year
51.45%
0.68%
52.13%
2 Years
123.56%
1.36%
124.92%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 2.5 per share ex-dividend date: Feb-14-2025

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
24.30%
EBIT Growth (5y)
37.76%
EBIT to Interest (avg)
14.42
Debt to EBITDA (avg)
0.74
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.97
Tax Ratio
27.06%
Dividend Payout Ratio
12.53%
Pledged Shares
0
Institutional Holding
19.01%
ROCE (avg)
15.64%
ROE (avg)
12.28%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
33
Price to Book Value
3.06
EV to EBIT
16.90
EV to EBITDA
13.68
EV to Capital Employed
2.78
EV to Sales
2.90
PEG Ratio
1.88
Dividend Yield
0.56%
ROCE (Latest)
15.13%
ROE (Latest)
12.28%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 6 Schemes (3.93%)

FIIs

Held by 100 FIIs (8.64%)

Promoter with highest holding

Rashesh Chandrakant Gogri (4.23%)

Highest Public shareholder

Life Insurance Corporation Of India (6.06%)

Individual Investors Holdings

30.39%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 17.41% vs -17.54% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 35.46% vs -1.50% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "537.78",
          "val2": "458.03",
          "chgp": "17.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "128.61",
          "val2": "93.67",
          "chgp": "37.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.97",
          "val2": "5.51",
          "chgp": "80.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "73.99",
          "val2": "54.62",
          "chgp": "35.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.91%",
          "val2": "20.45%",
          "chgp": "3.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 12.85% vs -9.14% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 11.32% vs -3.92% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,013.52",
          "val2": "898.15",
          "chgp": "12.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "190.13",
          "val2": "172.86",
          "chgp": "9.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.34",
          "val2": "8.06",
          "chgp": "28.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "110.08",
          "val2": "98.89",
          "chgp": "11.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.76%",
          "val2": "19.25%",
          "chgp": "-0.49%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 15.18% vs -7.76% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 21.38% vs 0.69% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,551.30",
          "val2": "1,346.84",
          "chgp": "15.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "318.74",
          "val2": "268.53",
          "chgp": "18.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "20.31",
          "val2": "12.54",
          "chgp": "61.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "184.07",
          "val2": "151.65",
          "chgp": "21.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.55%",
          "val2": "19.94%",
          "chgp": "0.61%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -4.76% vs 62.11% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 12.10% vs 58.27% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,852.61",
          "val2": "1,945.23",
          "chgp": "-4.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "386.05",
          "val2": "342.04",
          "chgp": "12.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "17.21",
          "val2": "21.05",
          "chgp": "-18.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "216.90",
          "val2": "193.49",
          "chgp": "12.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.84%",
          "val2": "17.58%",
          "chgp": "3.26%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
537.78
458.03
17.41%
Operating Profit (PBDIT) excl Other Income
128.61
93.67
37.30%
Interest
9.97
5.51
80.94%
Exceptional Items
0.00
0.00
Consolidate Net Profit
73.99
54.62
35.46%
Operating Profit Margin (Excl OI)
23.91%
20.45%
3.46%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 17.41% vs -17.54% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 35.46% vs -1.50% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,013.52
898.15
12.85%
Operating Profit (PBDIT) excl Other Income
190.13
172.86
9.99%
Interest
10.34
8.06
28.29%
Exceptional Items
0.00
0.00
Consolidate Net Profit
110.08
98.89
11.32%
Operating Profit Margin (Excl OI)
18.76%
19.25%
-0.49%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 12.85% vs -9.14% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 11.32% vs -3.92% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,551.30
1,346.84
15.18%
Operating Profit (PBDIT) excl Other Income
318.74
268.53
18.70%
Interest
20.31
12.54
61.96%
Exceptional Items
0.00
0.00
Consolidate Net Profit
184.07
151.65
21.38%
Operating Profit Margin (Excl OI)
20.55%
19.94%
0.61%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 15.18% vs -7.76% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 21.38% vs 0.69% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,852.61
1,945.23
-4.76%
Operating Profit (PBDIT) excl Other Income
386.05
342.04
12.87%
Interest
17.21
21.05
-18.24%
Exceptional Items
0.00
0.00
Consolidate Net Profit
216.90
193.49
12.10%
Operating Profit Margin (Excl OI)
20.84%
17.58%
3.26%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -4.76% vs 62.11% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 12.10% vs 58.27% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Aarti Pharmalabs Ltd stock-summary
stock-summary
Aarti Pharmalabs Ltd
Mid Cap
Pharmaceuticals & Drugs
Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."